nodes	percent_of_prediction	percent_of_DWPC	metapath
Diltiazem—CYP2C9—brain cancer	0.579	1	CbGaD
Diltiazem—CYP2D6—Lomustine—brain cancer	0.063	0.231	CbGbCtD
Diltiazem—CYP2D6—Hydroxyurea—brain cancer	0.0477	0.175	CbGbCtD
Diltiazem—CYP3A4—Temozolomide—brain cancer	0.0471	0.173	CbGbCtD
Diltiazem—CYP3A4—Lomustine—brain cancer	0.04	0.147	CbGbCtD
Diltiazem—CYP3A5—Etoposide—brain cancer	0.0248	0.0911	CbGbCtD
Diltiazem—CYP2C8—Etoposide—brain cancer	0.0239	0.0876	CbGbCtD
Diltiazem—ABCB1—Etoposide—brain cancer	0.0161	0.0593	CbGbCtD
Diltiazem—CYP3A4—Etoposide—brain cancer	0.00968	0.0355	CbGbCtD
Diltiazem—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.0012	0.0517	CbGpPWpGaD
Diltiazem—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00107	0.0465	CbGpPWpGaD
Diltiazem—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000978	0.0423	CbGpPWpGaD
Diltiazem—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000959	0.0415	CbGpPWpGaD
Diltiazem—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000873	0.0378	CbGpPWpGaD
Diltiazem—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.000833	0.036	CbGpPWpGaD
Diltiazem—CYP3A7—Xenobiotics—CYP2C9—brain cancer	0.000825	0.0357	CbGpPWpGaD
Diltiazem—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.000743	0.0322	CbGpPWpGaD
Diltiazem—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.000684	0.0296	CbGpPWpGaD
Diltiazem—CYP3A5—Xenobiotics—CYP2C9—brain cancer	0.000596	0.0258	CbGpPWpGaD
Diltiazem—CYP3A5—Tamoxifen metabolism—CYP2C9—brain cancer	0.000573	0.0248	CbGpPWpGaD
Diltiazem—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.000516	0.0223	CbGpPWpGaD
Diltiazem—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.000497	0.0215	CbGpPWpGaD
Diltiazem—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000461	0.0199	CbGpPWpGaD
Diltiazem—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000443	0.0192	CbGpPWpGaD
Diltiazem—Phlebitis—Etoposide—brain cancer	0.000427	0.0034	CcSEcCtD
Diltiazem—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.000424	0.0183	CbGpPWpGaD
Diltiazem—Swelling—Etoposide—brain cancer	0.000417	0.00332	CcSEcCtD
Diltiazem—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.000414	0.00329	CcSEcCtD
Diltiazem—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.000414	0.00329	CcSEcCtD
Diltiazem—Syncope—Procarbazine—brain cancer	0.00041	0.00327	CcSEcCtD
Diltiazem—Leukopenia—Procarbazine—brain cancer	0.00041	0.00326	CcSEcCtD
Diltiazem—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000409	0.0177	CbGpPWpGaD
Diltiazem—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000408	0.0176	CbGpPWpGaD
Diltiazem—Cardiac failure congestive—Etoposide—brain cancer	0.000405	0.00323	CcSEcCtD
Diltiazem—Hallucination—Hydroxyurea—brain cancer	0.000405	0.00322	CcSEcCtD
Diltiazem—Loss of consciousness—Procarbazine—brain cancer	0.000402	0.0032	CcSEcCtD
Diltiazem—Abdominal distension—Temozolomide—brain cancer	0.0004	0.00318	CcSEcCtD
Diltiazem—Cough—Procarbazine—brain cancer	0.000399	0.00318	CcSEcCtD
Diltiazem—Arthralgia—Procarbazine—brain cancer	0.00039	0.0031	CcSEcCtD
Diltiazem—Myalgia—Procarbazine—brain cancer	0.00039	0.0031	CcSEcCtD
Diltiazem—Bronchitis—Temozolomide—brain cancer	0.000382	0.00304	CcSEcCtD
Diltiazem—Dry mouth—Procarbazine—brain cancer	0.000381	0.00303	CcSEcCtD
Diltiazem—Vomiting—Lomustine—brain cancer	0.000374	0.00298	CcSEcCtD
Diltiazem—Oedema—Procarbazine—brain cancer	0.000373	0.00297	CcSEcCtD
Diltiazem—Infection—Procarbazine—brain cancer	0.000371	0.00295	CcSEcCtD
Diltiazem—Hyperglycaemia—Carmustine—brain cancer	0.000371	0.00295	CcSEcCtD
Diltiazem—Angiopathy—Hydroxyurea—brain cancer	0.000369	0.00294	CcSEcCtD
Diltiazem—Shock—Procarbazine—brain cancer	0.000367	0.00293	CcSEcCtD
Diltiazem—Pollakiuria—Temozolomide—brain cancer	0.000367	0.00292	CcSEcCtD
Diltiazem—Erectile dysfunction—Temozolomide—brain cancer	0.000366	0.00291	CcSEcCtD
Diltiazem—Thrombocytopenia—Procarbazine—brain cancer	0.000366	0.00291	CcSEcCtD
Diltiazem—CACNG1—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—brain cancer	0.000365	0.0158	CbGpPWpGaD
Diltiazem—Tachycardia—Procarbazine—brain cancer	0.000364	0.0029	CcSEcCtD
Diltiazem—Photosensitivity reaction—Temozolomide—brain cancer	0.000362	0.00289	CcSEcCtD
Diltiazem—Weight increased—Temozolomide—brain cancer	0.000361	0.00288	CcSEcCtD
Diltiazem—Hyperhidrosis—Procarbazine—brain cancer	0.000361	0.00288	CcSEcCtD
Diltiazem—Renal failure—Carmustine—brain cancer	0.00036	0.00287	CcSEcCtD
Diltiazem—Alopecia—Hydroxyurea—brain cancer	0.000359	0.00286	CcSEcCtD
Diltiazem—Neuropathy peripheral—Carmustine—brain cancer	0.000359	0.00286	CcSEcCtD
Diltiazem—Hyperglycaemia—Temozolomide—brain cancer	0.000358	0.00285	CcSEcCtD
Diltiazem—Urinary tract infection—Carmustine—brain cancer	0.000356	0.00284	CcSEcCtD
Diltiazem—Anorexia—Procarbazine—brain cancer	0.000356	0.00284	CcSEcCtD
Diltiazem—Erythema—Hydroxyurea—brain cancer	0.000354	0.00282	CcSEcCtD
Diltiazem—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000351	0.0028	CcSEcCtD
Diltiazem—Cardiac arrest—Etoposide—brain cancer	0.00035	0.00278	CcSEcCtD
Diltiazem—Nausea—Lomustine—brain cancer	0.000349	0.00278	CcSEcCtD
Diltiazem—Hypotension—Procarbazine—brain cancer	0.000349	0.00278	CcSEcCtD
Diltiazem—Neuropathy peripheral—Temozolomide—brain cancer	0.000347	0.00276	CcSEcCtD
Diltiazem—Urinary tract infection—Temozolomide—brain cancer	0.000344	0.00274	CcSEcCtD
Diltiazem—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000342	0.0148	CbGpPWpGaD
Diltiazem—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00034	0.00271	CcSEcCtD
Diltiazem—CYP3A7—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000338	0.0146	CbGpPWpGaD
Diltiazem—Insomnia—Procarbazine—brain cancer	0.000338	0.00269	CcSEcCtD
Diltiazem—Paraesthesia—Procarbazine—brain cancer	0.000335	0.00267	CcSEcCtD
Diltiazem—Sinusitis—Temozolomide—brain cancer	0.000332	0.00265	CcSEcCtD
Diltiazem—Somnolence—Procarbazine—brain cancer	0.000332	0.00264	CcSEcCtD
Diltiazem—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000331	0.00264	CcSEcCtD
Diltiazem—Cramp muscle—Etoposide—brain cancer	0.000331	0.00264	CcSEcCtD
Diltiazem—Ill-defined disorder—Hydroxyurea—brain cancer	0.000329	0.00262	CcSEcCtD
Diltiazem—Hallucination—Carmustine—brain cancer	0.000327	0.00261	CcSEcCtD
Diltiazem—Decreased appetite—Procarbazine—brain cancer	0.000325	0.00259	CcSEcCtD
Diltiazem—Oedema peripheral—Carmustine—brain cancer	0.000324	0.00258	CcSEcCtD
Diltiazem—Fatigue—Procarbazine—brain cancer	0.000322	0.00256	CcSEcCtD
Diltiazem—Malaise—Hydroxyurea—brain cancer	0.000319	0.00254	CcSEcCtD
Diltiazem—Constipation—Procarbazine—brain cancer	0.000319	0.00254	CcSEcCtD
Diltiazem—Pain—Procarbazine—brain cancer	0.000319	0.00254	CcSEcCtD
Diltiazem—Hepatitis—Temozolomide—brain cancer	0.000318	0.00253	CcSEcCtD
Diltiazem—Leukopenia—Hydroxyurea—brain cancer	0.000317	0.00252	CcSEcCtD
Diltiazem—Visual impairment—Carmustine—brain cancer	0.000317	0.00252	CcSEcCtD
Diltiazem—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000316	0.0137	CbGpPWpGaD
Diltiazem—Hallucination—Temozolomide—brain cancer	0.000316	0.00252	CcSEcCtD
Diltiazem—Pharyngitis—Temozolomide—brain cancer	0.000315	0.00251	CcSEcCtD
Diltiazem—Urinary tract disorder—Temozolomide—brain cancer	0.000314	0.0025	CcSEcCtD
Diltiazem—Oedema peripheral—Temozolomide—brain cancer	0.000313	0.00249	CcSEcCtD
Diltiazem—Urethral disorder—Temozolomide—brain cancer	0.000312	0.00248	CcSEcCtD
Diltiazem—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000309	0.0134	CbGpPWpGaD
Diltiazem—Feeling abnormal—Procarbazine—brain cancer	0.000308	0.00245	CcSEcCtD
Diltiazem—Eye disorder—Carmustine—brain cancer	0.000307	0.00245	CcSEcCtD
Diltiazem—Visual impairment—Temozolomide—brain cancer	0.000306	0.00244	CcSEcCtD
Diltiazem—Flushing—Carmustine—brain cancer	0.000305	0.00243	CcSEcCtD
Diltiazem—Erythema multiforme—Temozolomide—brain cancer	0.0003	0.00239	CcSEcCtD
Diltiazem—Discomfort—Hydroxyurea—brain cancer	0.000298	0.00237	CcSEcCtD
Diltiazem—Eye disorder—Temozolomide—brain cancer	0.000297	0.00237	CcSEcCtD
Diltiazem—Urticaria—Procarbazine—brain cancer	0.000297	0.00236	CcSEcCtD
Diltiazem—Tinnitus—Temozolomide—brain cancer	0.000296	0.00236	CcSEcCtD
Diltiazem—Abdominal pain—Procarbazine—brain cancer	0.000295	0.00235	CcSEcCtD
Diltiazem—Body temperature increased—Procarbazine—brain cancer	0.000295	0.00235	CcSEcCtD
Diltiazem—Cardiac disorder—Temozolomide—brain cancer	0.000295	0.00235	CcSEcCtD
Diltiazem—Flushing—Temozolomide—brain cancer	0.000295	0.00235	CcSEcCtD
Diltiazem—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000294	0.0127	CbGpPWpGaD
Diltiazem—Arrhythmia—Carmustine—brain cancer	0.000294	0.00234	CcSEcCtD
Diltiazem—Alopecia—Carmustine—brain cancer	0.000291	0.00231	CcSEcCtD
Diltiazem—Oedema—Hydroxyurea—brain cancer	0.000289	0.0023	CcSEcCtD
Diltiazem—Angiopathy—Temozolomide—brain cancer	0.000288	0.0023	CcSEcCtD
Diltiazem—Infection—Hydroxyurea—brain cancer	0.000287	0.00229	CcSEcCtD
Diltiazem—Mediastinal disorder—Temozolomide—brain cancer	0.000286	0.00228	CcSEcCtD
Diltiazem—Erythema—Carmustine—brain cancer	0.000286	0.00228	CcSEcCtD
Diltiazem—Malnutrition—Carmustine—brain cancer	0.000286	0.00228	CcSEcCtD
Diltiazem—Nervous system disorder—Hydroxyurea—brain cancer	0.000283	0.00226	CcSEcCtD
Diltiazem—Thrombocytopenia—Hydroxyurea—brain cancer	0.000283	0.00225	CcSEcCtD
Diltiazem—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000281	0.00224	CcSEcCtD
Diltiazem—Alopecia—Temozolomide—brain cancer	0.000281	0.00224	CcSEcCtD
Diltiazem—Acute coronary syndrome—Etoposide—brain cancer	0.000279	0.00222	CcSEcCtD
Diltiazem—Renal failure—Etoposide—brain cancer	0.000278	0.00222	CcSEcCtD
Diltiazem—Neuropathy peripheral—Etoposide—brain cancer	0.000278	0.00221	CcSEcCtD
Diltiazem—Myocardial infarction—Etoposide—brain cancer	0.000278	0.00221	CcSEcCtD
Diltiazem—CYP3A7—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000278	0.012	CbGpPWpGaD
Diltiazem—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000277	0.012	CbGpPWpGaD
Diltiazem—Erythema—Temozolomide—brain cancer	0.000277	0.0022	CcSEcCtD
Diltiazem—Malnutrition—Temozolomide—brain cancer	0.000277	0.0022	CcSEcCtD
Diltiazem—Anorexia—Hydroxyurea—brain cancer	0.000275	0.00219	CcSEcCtD
Diltiazem—Hypersensitivity—Procarbazine—brain cancer	0.000275	0.00219	CcSEcCtD
Diltiazem—Dysgeusia—Temozolomide—brain cancer	0.000271	0.00216	CcSEcCtD
Diltiazem—Vision blurred—Carmustine—brain cancer	0.00027	0.00215	CcSEcCtD
Diltiazem—Tremor—Carmustine—brain cancer	0.000268	0.00214	CcSEcCtD
Diltiazem—Asthenia—Procarbazine—brain cancer	0.000268	0.00213	CcSEcCtD
Diltiazem—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000267	0.0115	CbGpPWpGaD
Diltiazem—Agranulocytosis—Etoposide—brain cancer	0.000264	0.00211	CcSEcCtD
Diltiazem—Pruritus—Procarbazine—brain cancer	0.000264	0.0021	CcSEcCtD
Diltiazem—Vision blurred—Temozolomide—brain cancer	0.000261	0.00208	CcSEcCtD
Diltiazem—Tremor—Temozolomide—brain cancer	0.000259	0.00206	CcSEcCtD
Diltiazem—Dyspnoea—Hydroxyurea—brain cancer	0.000258	0.00205	CcSEcCtD
Diltiazem—Somnolence—Hydroxyurea—brain cancer	0.000257	0.00205	CcSEcCtD
Diltiazem—Ill-defined disorder—Temozolomide—brain cancer	0.000257	0.00204	CcSEcCtD
Diltiazem—Leukopenia—Carmustine—brain cancer	0.000256	0.00204	CcSEcCtD
Diltiazem—Diarrhoea—Procarbazine—brain cancer	0.000255	0.00204	CcSEcCtD
Diltiazem—Dyspepsia—Hydroxyurea—brain cancer	0.000254	0.00203	CcSEcCtD
Diltiazem—Angioedema—Temozolomide—brain cancer	0.000253	0.00201	CcSEcCtD
Diltiazem—Decreased appetite—Hydroxyurea—brain cancer	0.000251	0.002	CcSEcCtD
Diltiazem—Urinary tract disorder—Etoposide—brain cancer	0.000251	0.002	CcSEcCtD
Diltiazem—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00025	0.00199	CcSEcCtD
Diltiazem—Malaise—Temozolomide—brain cancer	0.000249	0.00199	CcSEcCtD
Diltiazem—Urethral disorder—Etoposide—brain cancer	0.000249	0.00199	CcSEcCtD
Diltiazem—Fatigue—Hydroxyurea—brain cancer	0.000249	0.00198	CcSEcCtD
Diltiazem—Vertigo—Temozolomide—brain cancer	0.000249	0.00198	CcSEcCtD
Diltiazem—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000248	0.0107	CbGpPWpGaD
Diltiazem—Leukopenia—Temozolomide—brain cancer	0.000248	0.00197	CcSEcCtD
Diltiazem—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000248	0.0107	CbGpPWpGaD
Diltiazem—Constipation—Hydroxyurea—brain cancer	0.000247	0.00197	CcSEcCtD
Diltiazem—Pain—Hydroxyurea—brain cancer	0.000247	0.00197	CcSEcCtD
Diltiazem—Dizziness—Procarbazine—brain cancer	0.000247	0.00197	CcSEcCtD
Diltiazem—Palpitations—Temozolomide—brain cancer	0.000244	0.00195	CcSEcCtD
Diltiazem—CYP3A5—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000244	0.0106	CbGpPWpGaD
Diltiazem—Myalgia—Carmustine—brain cancer	0.000244	0.00194	CcSEcCtD
Diltiazem—Chest pain—Carmustine—brain cancer	0.000244	0.00194	CcSEcCtD
Diltiazem—Cough—Temozolomide—brain cancer	0.000241	0.00192	CcSEcCtD
Diltiazem—Erythema multiforme—Etoposide—brain cancer	0.00024	0.00192	CcSEcCtD
Diltiazem—Feeling abnormal—Hydroxyurea—brain cancer	0.000238	0.0019	CcSEcCtD
Diltiazem—Eye disorder—Etoposide—brain cancer	0.000238	0.00189	CcSEcCtD
Diltiazem—Vomiting—Procarbazine—brain cancer	0.000237	0.00189	CcSEcCtD
Diltiazem—Cardiac disorder—Etoposide—brain cancer	0.000236	0.00188	CcSEcCtD
Diltiazem—Flushing—Etoposide—brain cancer	0.000236	0.00188	CcSEcCtD
Diltiazem—Myalgia—Temozolomide—brain cancer	0.000236	0.00188	CcSEcCtD
Diltiazem—Arthralgia—Temozolomide—brain cancer	0.000236	0.00188	CcSEcCtD
Diltiazem—Rash—Procarbazine—brain cancer	0.000235	0.00188	CcSEcCtD
Diltiazem—Dermatitis—Procarbazine—brain cancer	0.000235	0.00187	CcSEcCtD
Diltiazem—Headache—Procarbazine—brain cancer	0.000234	0.00186	CcSEcCtD
Diltiazem—Oedema—Carmustine—brain cancer	0.000234	0.00186	CcSEcCtD
Diltiazem—Discomfort—Temozolomide—brain cancer	0.000233	0.00185	CcSEcCtD
Diltiazem—Infection—Carmustine—brain cancer	0.000232	0.00185	CcSEcCtD
Diltiazem—Angiopathy—Etoposide—brain cancer	0.000231	0.00184	CcSEcCtD
Diltiazem—Dry mouth—Temozolomide—brain cancer	0.00023	0.00183	CcSEcCtD
Diltiazem—Mediastinal disorder—Etoposide—brain cancer	0.000229	0.00183	CcSEcCtD
Diltiazem—Thrombocytopenia—Carmustine—brain cancer	0.000229	0.00182	CcSEcCtD
Diltiazem—Body temperature increased—Hydroxyurea—brain cancer	0.000228	0.00182	CcSEcCtD
Diltiazem—Tachycardia—Carmustine—brain cancer	0.000228	0.00182	CcSEcCtD
Diltiazem—Oedema—Temozolomide—brain cancer	0.000226	0.0018	CcSEcCtD
Diltiazem—Alopecia—Etoposide—brain cancer	0.000225	0.00179	CcSEcCtD
Diltiazem—Infection—Temozolomide—brain cancer	0.000224	0.00179	CcSEcCtD
Diltiazem—Anorexia—Carmustine—brain cancer	0.000223	0.00177	CcSEcCtD
Diltiazem—Nausea—Procarbazine—brain cancer	0.000222	0.00177	CcSEcCtD
Diltiazem—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000221	0.00958	CbGpPWpGaD
Diltiazem—Nervous system disorder—Temozolomide—brain cancer	0.000221	0.00176	CcSEcCtD
Diltiazem—Thrombocytopenia—Temozolomide—brain cancer	0.000221	0.00176	CcSEcCtD
Diltiazem—Hypotension—Carmustine—brain cancer	0.000218	0.00174	CcSEcCtD
Diltiazem—Hyperhidrosis—Temozolomide—brain cancer	0.000218	0.00174	CcSEcCtD
Diltiazem—Dysgeusia—Etoposide—brain cancer	0.000217	0.00173	CcSEcCtD
Diltiazem—Anorexia—Temozolomide—brain cancer	0.000215	0.00171	CcSEcCtD
Diltiazem—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000214	0.00927	CbGpPWpGaD
Diltiazem—Hypersensitivity—Hydroxyurea—brain cancer	0.000213	0.0017	CcSEcCtD
Diltiazem—Musculoskeletal discomfort—Carmustine—brain cancer	0.000213	0.0017	CcSEcCtD
Diltiazem—Muscle spasms—Etoposide—brain cancer	0.000213	0.0017	CcSEcCtD
Diltiazem—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000212	0.00915	CbGpPWpGaD
Diltiazem—Insomnia—Carmustine—brain cancer	0.000211	0.00168	CcSEcCtD
Diltiazem—CYP3A5—Irinotecan Pathway—APC—brain cancer	0.00021	0.00909	CbGpPWpGaD
Diltiazem—Paraesthesia—Carmustine—brain cancer	0.00021	0.00167	CcSEcCtD
Diltiazem—Dyspnoea—Carmustine—brain cancer	0.000208	0.00166	CcSEcCtD
Diltiazem—Somnolence—Carmustine—brain cancer	0.000208	0.00165	CcSEcCtD
Diltiazem—Asthenia—Hydroxyurea—brain cancer	0.000207	0.00165	CcSEcCtD
Diltiazem—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000206	0.00164	CcSEcCtD
Diltiazem—Ill-defined disorder—Etoposide—brain cancer	0.000205	0.00164	CcSEcCtD
Diltiazem—Insomnia—Temozolomide—brain cancer	0.000204	0.00163	CcSEcCtD
Diltiazem—Decreased appetite—Carmustine—brain cancer	0.000203	0.00162	CcSEcCtD
Diltiazem—Paraesthesia—Temozolomide—brain cancer	0.000203	0.00161	CcSEcCtD
Diltiazem—Gastrointestinal disorder—Carmustine—brain cancer	0.000202	0.00161	CcSEcCtD
Diltiazem—Dyspnoea—Temozolomide—brain cancer	0.000201	0.0016	CcSEcCtD
Diltiazem—Somnolence—Temozolomide—brain cancer	0.000201	0.0016	CcSEcCtD
Diltiazem—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000201	0.00868	CbGpPWpGaD
Diltiazem—Pain—Carmustine—brain cancer	0.0002	0.00159	CcSEcCtD
Diltiazem—Constipation—Carmustine—brain cancer	0.0002	0.00159	CcSEcCtD
Diltiazem—Malaise—Etoposide—brain cancer	0.0002	0.00159	CcSEcCtD
Diltiazem—Vertigo—Etoposide—brain cancer	0.000199	0.00158	CcSEcCtD
Diltiazem—Dyspepsia—Temozolomide—brain cancer	0.000199	0.00158	CcSEcCtD
Diltiazem—Leukopenia—Etoposide—brain cancer	0.000198	0.00158	CcSEcCtD
Diltiazem—Diarrhoea—Hydroxyurea—brain cancer	0.000198	0.00157	CcSEcCtD
Diltiazem—Decreased appetite—Temozolomide—brain cancer	0.000196	0.00156	CcSEcCtD
Diltiazem—Gastrointestinal disorder—Temozolomide—brain cancer	0.000195	0.00155	CcSEcCtD
Diltiazem—Fatigue—Temozolomide—brain cancer	0.000195	0.00155	CcSEcCtD
Diltiazem—Loss of consciousness—Etoposide—brain cancer	0.000195	0.00155	CcSEcCtD
Diltiazem—Cough—Etoposide—brain cancer	0.000193	0.00154	CcSEcCtD
Diltiazem—Pain—Temozolomide—brain cancer	0.000193	0.00154	CcSEcCtD
Diltiazem—Constipation—Temozolomide—brain cancer	0.000193	0.00154	CcSEcCtD
Diltiazem—Feeling abnormal—Carmustine—brain cancer	0.000193	0.00153	CcSEcCtD
Diltiazem—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000191	0.00828	CbGpPWpGaD
Diltiazem—Dizziness—Hydroxyurea—brain cancer	0.000191	0.00152	CcSEcCtD
Diltiazem—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00019	0.00823	CbGpPWpGaD
Diltiazem—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000189	0.00817	CbGpPWpGaD
Diltiazem—Chest pain—Etoposide—brain cancer	0.000188	0.0015	CcSEcCtD
Diltiazem—Discomfort—Etoposide—brain cancer	0.000186	0.00148	CcSEcCtD
Diltiazem—Feeling abnormal—Temozolomide—brain cancer	0.000186	0.00148	CcSEcCtD
Diltiazem—Abdominal pain—Carmustine—brain cancer	0.000185	0.00147	CcSEcCtD
Diltiazem—Body temperature increased—Carmustine—brain cancer	0.000185	0.00147	CcSEcCtD
Diltiazem—Vomiting—Hydroxyurea—brain cancer	0.000184	0.00146	CcSEcCtD
Diltiazem—Rash—Hydroxyurea—brain cancer	0.000182	0.00145	CcSEcCtD
Diltiazem—Dermatitis—Hydroxyurea—brain cancer	0.000182	0.00145	CcSEcCtD
Diltiazem—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000181	0.00784	CbGpPWpGaD
Diltiazem—Headache—Hydroxyurea—brain cancer	0.000181	0.00144	CcSEcCtD
Diltiazem—Infection—Etoposide—brain cancer	0.000179	0.00143	CcSEcCtD
Diltiazem—Urticaria—Temozolomide—brain cancer	0.000179	0.00143	CcSEcCtD
Diltiazem—Abdominal pain—Temozolomide—brain cancer	0.000178	0.00142	CcSEcCtD
Diltiazem—Body temperature increased—Temozolomide—brain cancer	0.000178	0.00142	CcSEcCtD
Diltiazem—Thrombocytopenia—Etoposide—brain cancer	0.000177	0.00141	CcSEcCtD
Diltiazem—Tachycardia—Etoposide—brain cancer	0.000176	0.0014	CcSEcCtD
Diltiazem—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000176	0.00761	CbGpPWpGaD
Diltiazem—Hyperhidrosis—Etoposide—brain cancer	0.000175	0.00139	CcSEcCtD
Diltiazem—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000174	0.00752	CbGpPWpGaD
Diltiazem—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000174	0.00751	CbGpPWpGaD
Diltiazem—Anorexia—Etoposide—brain cancer	0.000172	0.00137	CcSEcCtD
Diltiazem—Hypersensitivity—Carmustine—brain cancer	0.000172	0.00137	CcSEcCtD
Diltiazem—Nausea—Hydroxyurea—brain cancer	0.000172	0.00137	CcSEcCtD
Diltiazem—Hypotension—Etoposide—brain cancer	0.000169	0.00134	CcSEcCtD
Diltiazem—Asthenia—Carmustine—brain cancer	0.000168	0.00134	CcSEcCtD
Diltiazem—Hypersensitivity—Temozolomide—brain cancer	0.000166	0.00132	CcSEcCtD
Diltiazem—Paraesthesia—Etoposide—brain cancer	0.000162	0.00129	CcSEcCtD
Diltiazem—Asthenia—Temozolomide—brain cancer	0.000162	0.00129	CcSEcCtD
Diltiazem—Dyspnoea—Etoposide—brain cancer	0.000161	0.00128	CcSEcCtD
Diltiazem—Somnolence—Etoposide—brain cancer	0.000161	0.00128	CcSEcCtD
Diltiazem—Diarrhoea—Carmustine—brain cancer	0.00016	0.00127	CcSEcCtD
Diltiazem—Pruritus—Temozolomide—brain cancer	0.00016	0.00127	CcSEcCtD
Diltiazem—Decreased appetite—Etoposide—brain cancer	0.000157	0.00125	CcSEcCtD
Diltiazem—Gastrointestinal disorder—Etoposide—brain cancer	0.000156	0.00124	CcSEcCtD
Diltiazem—Fatigue—Etoposide—brain cancer	0.000156	0.00124	CcSEcCtD
Diltiazem—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000155	0.00671	CbGpPWpGaD
Diltiazem—Dizziness—Carmustine—brain cancer	0.000154	0.00123	CcSEcCtD
Diltiazem—Pain—Etoposide—brain cancer	0.000154	0.00123	CcSEcCtD
Diltiazem—Constipation—Etoposide—brain cancer	0.000154	0.00123	CcSEcCtD
Diltiazem—Diarrhoea—Temozolomide—brain cancer	0.000154	0.00123	CcSEcCtD
Diltiazem—Dizziness—Temozolomide—brain cancer	0.000149	0.00119	CcSEcCtD
Diltiazem—Feeling abnormal—Etoposide—brain cancer	0.000149	0.00119	CcSEcCtD
Diltiazem—Vomiting—Carmustine—brain cancer	0.000149	0.00118	CcSEcCtD
Diltiazem—CYP3A7—Biological oxidations—CYP2C9—brain cancer	0.000147	0.00638	CbGpPWpGaD
Diltiazem—Rash—Carmustine—brain cancer	0.000147	0.00117	CcSEcCtD
Diltiazem—Dermatitis—Carmustine—brain cancer	0.000147	0.00117	CcSEcCtD
Diltiazem—Headache—Carmustine—brain cancer	0.000146	0.00117	CcSEcCtD
Diltiazem—CYP3A7—Metapathway biotransformation—CYP2C9—brain cancer	0.000145	0.00629	CbGpPWpGaD
Diltiazem—Vomiting—Temozolomide—brain cancer	0.000144	0.00114	CcSEcCtD
Diltiazem—Urticaria—Etoposide—brain cancer	0.000144	0.00114	CcSEcCtD
Diltiazem—Body temperature increased—Etoposide—brain cancer	0.000143	0.00114	CcSEcCtD
Diltiazem—Abdominal pain—Etoposide—brain cancer	0.000143	0.00114	CcSEcCtD
Diltiazem—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000143	0.00617	CbGpPWpGaD
Diltiazem—Rash—Temozolomide—brain cancer	0.000142	0.00113	CcSEcCtD
Diltiazem—Dermatitis—Temozolomide—brain cancer	0.000142	0.00113	CcSEcCtD
Diltiazem—Headache—Temozolomide—brain cancer	0.000141	0.00113	CcSEcCtD
Diltiazem—Nausea—Carmustine—brain cancer	0.000139	0.00111	CcSEcCtD
Diltiazem—Nausea—Temozolomide—brain cancer	0.000134	0.00107	CcSEcCtD
Diltiazem—Hypersensitivity—Etoposide—brain cancer	0.000133	0.00106	CcSEcCtD
Diltiazem—Asthenia—Etoposide—brain cancer	0.00013	0.00103	CcSEcCtD
Diltiazem—Pruritus—Etoposide—brain cancer	0.000128	0.00102	CcSEcCtD
Diltiazem—Diarrhoea—Etoposide—brain cancer	0.000124	0.000985	CcSEcCtD
Diltiazem—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.00012	0.0052	CbGpPWpGaD
Diltiazem—Dizziness—Etoposide—brain cancer	0.000119	0.000952	CcSEcCtD
Diltiazem—CACNA1S—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—brain cancer	0.000119	0.00516	CbGpPWpGaD
Diltiazem—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000115	0.00498	CbGpPWpGaD
Diltiazem—Vomiting—Etoposide—brain cancer	0.000115	0.000915	CcSEcCtD
Diltiazem—Rash—Etoposide—brain cancer	0.000114	0.000907	CcSEcCtD
Diltiazem—Dermatitis—Etoposide—brain cancer	0.000114	0.000906	CcSEcCtD
Diltiazem—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000114	0.00491	CbGpPWpGaD
Diltiazem—CACNA1S—Axon guidance—TRPC6—brain cancer	0.000113	0.0049	CbGpPWpGaD
Diltiazem—Headache—Etoposide—brain cancer	0.000113	0.000901	CcSEcCtD
Diltiazem—Nausea—Etoposide—brain cancer	0.000107	0.000855	CcSEcCtD
Diltiazem—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000107	0.00464	CbGpPWpGaD
Diltiazem—CYP3A5—Biological oxidations—CYP2C9—brain cancer	0.000107	0.00461	CbGpPWpGaD
Diltiazem—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	0.000105	0.00455	CbGpPWpGaD
Diltiazem—CYP3A4—Irinotecan Pathway—APC—brain cancer	9.77e-05	0.00423	CbGpPWpGaD
Diltiazem—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	9.33e-05	0.00403	CbGpPWpGaD
Diltiazem—CYP2C8—Biological oxidations—CYP2C9—brain cancer	9.23e-05	0.00399	CbGpPWpGaD
Diltiazem—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	9.11e-05	0.00394	CbGpPWpGaD
Diltiazem—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	8.67e-05	0.00375	CbGpPWpGaD
Diltiazem—CACNA1C—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—brain cancer	8.52e-05	0.00368	CbGpPWpGaD
Diltiazem—CYP2C19—Biological oxidations—CYP2C9—brain cancer	8.24e-05	0.00356	CbGpPWpGaD
Diltiazem—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	8.13e-05	0.00352	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—TRPC6—brain cancer	8.09e-05	0.0035	CbGpPWpGaD
Diltiazem—CACNA1C—Axon guidance—TRPC6—brain cancer	8.09e-05	0.0035	CbGpPWpGaD
Diltiazem—CYP2D6—Biological oxidations—CYP2C9—brain cancer	7.58e-05	0.00328	CbGpPWpGaD
Diltiazem—CACNA1S—Alzheimers Disease—TP53—brain cancer	7.54e-05	0.00326	CbGpPWpGaD
Diltiazem—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	7.51e-05	0.00325	CbGpPWpGaD
Diltiazem—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	7.48e-05	0.00323	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—TRPC6—brain cancer	5.77e-05	0.0025	CbGpPWpGaD
Diltiazem—CACNA1C—Alzheimers Disease—TP53—brain cancer	5.38e-05	0.00233	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—HES1—brain cancer	5.21e-05	0.00225	CbGpPWpGaD
Diltiazem—ABCB1—Allograft Rejection—PDGFRA—brain cancer	5.13e-05	0.00222	CbGpPWpGaD
Diltiazem—CYP3A4—Biological oxidations—CYP2C9—brain cancer	4.96e-05	0.00214	CbGpPWpGaD
Diltiazem—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	4.89e-05	0.00211	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	4.28e-05	0.00185	CbGpPWpGaD
Diltiazem—CACNA1S—Axon guidance—ERBB2—brain cancer	4.19e-05	0.00181	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—CYP2C9—brain cancer	4.12e-05	0.00178	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—CDK4—brain cancer	4.09e-05	0.00177	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	4.05e-05	0.00175	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—HES1—brain cancer	3.72e-05	0.00161	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.55e-05	0.00153	CbGpPWpGaD
Diltiazem—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	3.54e-05	0.00153	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—BSG—brain cancer	3.5e-05	0.00151	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	3.42e-05	0.00148	CbGpPWpGaD
Diltiazem—CACNA1S—Axon guidance—VEGFA—brain cancer	3.23e-05	0.00139	CbGpPWpGaD
Diltiazem—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	3.2e-05	0.00139	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.16e-05	0.00137	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—IDH1—brain cancer	3.01e-05	0.0013	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—RELA—brain cancer	3.01e-05	0.0013	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—ERBB2—brain cancer	2.99e-05	0.00129	CbGpPWpGaD
Diltiazem—CACNA1C—Axon guidance—ERBB2—brain cancer	2.99e-05	0.00129	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—CDK4—brain cancer	2.92e-05	0.00126	CbGpPWpGaD
Diltiazem—CACNA1S—Axon guidance—EGFR—brain cancer	2.9e-05	0.00126	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	2.81e-05	0.00121	CbGpPWpGaD
Diltiazem—ABCB1—Allograft Rejection—IL2—brain cancer	2.8e-05	0.00121	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	2.75e-05	0.00119	CbGpPWpGaD
Diltiazem—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	2.74e-05	0.00119	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	2.72e-05	0.00118	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—CTNNB1—brain cancer	2.61e-05	0.00113	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.59e-05	0.00112	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	2.53e-05	0.00109	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—CYP2C9—brain cancer	2.52e-05	0.00109	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	2.41e-05	0.00104	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—ENO2—brain cancer	2.38e-05	0.00103	CbGpPWpGaD
Diltiazem—ABCB1—Allograft Rejection—VEGFA—brain cancer	2.38e-05	0.00103	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.31e-05	0.001	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—VEGFA—brain cancer	2.3e-05	0.000995	CbGpPWpGaD
Diltiazem—CACNA1C—Axon guidance—VEGFA—brain cancer	2.3e-05	0.000995	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—STAT3—brain cancer	2.28e-05	0.000986	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—RELA—brain cancer	2.15e-05	0.000928	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—BSG—brain cancer	2.14e-05	0.000927	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—ERBB2—brain cancer	2.13e-05	0.000922	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.11e-05	0.000912	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	2.08e-05	0.000901	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—EGFR—brain cancer	2.07e-05	0.000896	CbGpPWpGaD
Diltiazem—CACNA1C—Axon guidance—EGFR—brain cancer	2.07e-05	0.000895	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	1.96e-05	0.000848	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—CTNNB1—brain cancer	1.86e-05	0.000807	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—IDH1—brain cancer	1.84e-05	0.000797	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—CYP2C9—brain cancer	1.82e-05	0.000788	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—VEGFA—brain cancer	1.64e-05	0.00071	CbGpPWpGaD
Diltiazem—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	1.64e-05	0.000708	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—STAT3—brain cancer	1.63e-05	0.000703	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—CYP2C9—brain cancer	1.58e-05	0.000683	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—BSG—brain cancer	1.55e-05	0.00067	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	1.52e-05	0.000659	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—EGFR—brain cancer	1.48e-05	0.000639	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—ENO2—brain cancer	1.46e-05	0.00063	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—CYP2C9—brain cancer	1.41e-05	0.00061	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—CYP2C9—brain cancer	1.38e-05	0.000595	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.35e-05	0.000582	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—BSG—brain cancer	1.34e-05	0.000581	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—IDH1—brain cancer	1.33e-05	0.000576	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.33e-05	0.000576	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—CYP2C9—brain cancer	1.3e-05	0.000561	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—BSG—brain cancer	1.2e-05	0.000518	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.17e-05	0.000507	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—BSG—brain cancer	1.17e-05	0.000506	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—IDH1—brain cancer	1.15e-05	0.000499	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—BSG—brain cancer	1.1e-05	0.000477	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—BSG—brain cancer	1.09e-05	0.000473	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—PIK3CG—brain cancer	1.09e-05	0.000472	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.08e-05	0.000467	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.06e-05	0.000456	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—ENO2—brain cancer	1.05e-05	0.000456	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—IDH1—brain cancer	1.03e-05	0.000446	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—IDH1—brain cancer	1.01e-05	0.000435	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—IDH1—brain cancer	9.48e-06	0.00041	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.4e-06	0.000407	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—IDH1—brain cancer	9.4e-06	0.000406	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—ENO2—brain cancer	9.13e-06	0.000395	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	8.86e-06	0.000383	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—CYP2C9—brain cancer	8.47e-06	0.000367	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.39e-06	0.000363	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—ENO2—brain cancer	8.15e-06	0.000352	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—ENO2—brain cancer	7.95e-06	0.000344	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.65e-06	0.000331	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—ENO2—brain cancer	7.49e-06	0.000324	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—ENO2—brain cancer	7.43e-06	0.000321	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—BSG—brain cancer	7.21e-06	0.000312	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—PIK3CG—brain cancer	6.69e-06	0.000289	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—IDH1—brain cancer	6.2e-06	0.000268	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—ENO2—brain cancer	4.9e-06	0.000212	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—PIK3CG—brain cancer	4.83e-06	0.000209	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—PIK3CG—brain cancer	4.19e-06	0.000181	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—PIK3CG—brain cancer	3.74e-06	0.000162	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—PIK3CG—brain cancer	3.65e-06	0.000158	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—PIK3CG—brain cancer	3.44e-06	0.000149	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—PIK3CG—brain cancer	3.41e-06	0.000147	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—PIK3CG—brain cancer	2.25e-06	9.72e-05	CbGpPWpGaD
